These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 23723075)
1. HDAC6 and SIRT2 regulate the acetylation state and oncogenic activity of mutant K-RAS. Yang MH; Laurent G; Bause AS; Spang R; German N; Haigis MC; Haigis KM Mol Cancer Res; 2013 Sep; 11(9):1072-7. PubMed ID: 23723075 [TBL] [Abstract][Full Text] [Related]
2. SIRT2 deletion enhances KRAS-induced tumorigenesis in vivo by regulating K147 acetylation status. Song HY; Biancucci M; Kang HJ; O'Callaghan C; Park SH; Principe DR; Jiang H; Yan Y; Satchell KF; Raparia K; Gius D; Vassilopoulos A Oncotarget; 2016 Dec; 7(49):80336-80349. PubMed ID: 27637077 [TBL] [Abstract][Full Text] [Related]
3. Oncogenic K-ras confers SAHA resistance by up-regulating HDAC6 and c-myc expression. Wang Q; Tan R; Zhu X; Zhang Y; Tan Z; Su B; Li Y Oncotarget; 2016 Mar; 7(9):10064-72. PubMed ID: 26848526 [TBL] [Abstract][Full Text] [Related]
4. Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS. Taes I; Timmers M; Hersmus N; Bento-Abreu A; Van Den Bosch L; Van Damme P; Auwerx J; Robberecht W Hum Mol Genet; 2013 May; 22(9):1783-90. PubMed ID: 23364049 [TBL] [Abstract][Full Text] [Related]
5. Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma. Lee YS; Lee JW; Jang JW; Chi XZ; Kim JH; Li YH; Kim MK; Kim DM; Choi BS; Kim EG; Chung JH; Lee OJ; Lee YM; Suh JW; Chuang LS; Ito Y; Bae SC Cancer Cell; 2013 Nov; 24(5):603-16. PubMed ID: 24229708 [TBL] [Abstract][Full Text] [Related]
6. Insights into K-Ras 4B regulation by post-translational lysine acetylation. Knyphausen P; Lang F; Baldus L; Extra A; Lammers M Biol Chem; 2016 Oct; 397(10):1071-85. PubMed ID: 27176741 [TBL] [Abstract][Full Text] [Related]
7. SIRT2 and lysine fatty acylation regulate the transforming activity of K-Ras4a. Jing H; Zhang X; Wisner SA; Chen X; Spiegelman NA; Linder ME; Lin H Elife; 2017 Dec; 6():. PubMed ID: 29239724 [TBL] [Abstract][Full Text] [Related]
8. SIRT2 inactivation reveals a subset of hyperacetylated perinuclear microtubules inaccessible to HDAC6. Skoge RH; Ziegler M J Cell Sci; 2016 Aug; 129(15):2972-82. PubMed ID: 27311481 [TBL] [Abstract][Full Text] [Related]
9. Kruppel-like factor 5 is not required for K-RasG12D lung tumorigenesis, but represses ABCG2 expression and is associated with better disease-specific survival. Meyer SE; Hasenstein JR; Baktula A; Velu CS; Xu Y; Wan H; Whitsett JA; Gilks CB; Grimes HL Am J Pathol; 2010 Sep; 177(3):1503-13. PubMed ID: 20639455 [TBL] [Abstract][Full Text] [Related]
10. Structural and Mechanistic Insights into the Regulation of the Fundamental Rho Regulator RhoGDIα by Lysine Acetylation. Kuhlmann N; Wroblowski S; Knyphausen P; de Boor S; Brenig J; Zienert AY; Meyer-Teschendorf K; Praefcke GJK; Nolte H; Krüger M; Schacherl M; Baumann U; James LC; Chin JW; Lammers M J Biol Chem; 2016 Mar; 291(11):5484-5499. PubMed ID: 26719334 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylation at Ser-181 of oncogenic KRAS is required for tumor growth. Barceló C; Paco N; Morell M; Alvarez-Moya B; Bota-Rabassedas N; Jaumot M; Vilardell F; Capella G; Agell N Cancer Res; 2014 Feb; 74(4):1190-9. PubMed ID: 24371225 [TBL] [Abstract][Full Text] [Related]
12. Modulation of histone deacetylase 6 (HDAC6) nuclear import and tubulin deacetylase activity through acetylation. Liu Y; Peng L; Seto E; Huang S; Qiu Y J Biol Chem; 2012 Aug; 287(34):29168-74. PubMed ID: 22778253 [TBL] [Abstract][Full Text] [Related]
13. Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition-mediated cell death in K-ras mutant lung cancer cells. Yu JA; Li H; Meng X; Fullerton DA; Nemenoff RA; Mitchell JD; Weyant MJ J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1479-85. PubMed ID: 23026567 [TBL] [Abstract][Full Text] [Related]